BR112016017636A2 - Agente oralmente administrado a ruminantes e alimentação de ruminante contendo o mesmo - Google Patents

Agente oralmente administrado a ruminantes e alimentação de ruminante contendo o mesmo

Info

Publication number
BR112016017636A2
BR112016017636A2 BR112016017636A BR112016017636A BR112016017636A2 BR 112016017636 A2 BR112016017636 A2 BR 112016017636A2 BR 112016017636 A BR112016017636 A BR 112016017636A BR 112016017636 A BR112016017636 A BR 112016017636A BR 112016017636 A2 BR112016017636 A2 BR 112016017636A2
Authority
BR
Brazil
Prior art keywords
ruminants
orally administered
administered agent
same
feed containing
Prior art date
Application number
BR112016017636A
Other languages
English (en)
Other versions
BR112016017636B1 (pt
Inventor
Adachi Takuhiko
SEYAMA Tomohiro
HIRAYASU Hirofumi
Kasai Koji
FUJITANI Yasuhiro
Original Assignee
Morishita Jintan Co
Res Institute Of Environment Agriculture And Fisheries Osaka Prefecture
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Morishita Jintan Co, Res Institute Of Environment Agriculture And Fisheries Osaka Prefecture filed Critical Morishita Jintan Co
Publication of BR112016017636A2 publication Critical patent/BR112016017636A2/pt
Publication of BR112016017636B1 publication Critical patent/BR112016017636B1/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/105—Aliphatic or alicyclic compounds
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/174—Vitamins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K40/00—Shaping or working-up of animal feeding-stuffs
    • A23K40/30—Shaping or working-up of animal feeding-stuffs by encapsulating; by coating
    • A23K40/35—Making capsules specially adapted for ruminants
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/10—Feeding-stuffs specially adapted for particular animals for ruminants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J3/00—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms
    • A61J3/07—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms into the form of capsules or similar small containers for oral use
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A61K31/51—Thiamines, e.g. vitamin B1
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4816—Wall or shell material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4833—Encapsulating processes; Filling of capsules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/485—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4875—Compounds of unknown constitution, e.g. material from plants or animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K2035/11—Medicinal preparations comprising living procariotic cells
    • A61K2035/115—Probiotics

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Zoology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Food Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Animal Husbandry (AREA)
  • Birds (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Botany (AREA)
  • Fodder In General (AREA)
  • Medicinal Preparation (AREA)
  • Feed For Specific Animals (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

AGENTE ORALMENTE ADMINISTRADO A RUMINANTES E ALIMENTAÇÃO DE RUMINANTES CONTENDO O MESMO. A presente invenção fornece um agente oralmente administrado para ruminantes que alcança trato digestivo inferior sem decomposição no rume evitando a destruição do mesmo devido à ruminação, e é desintegrado e dissolvido in vivo. A presente invenção fornece um agente oralmente administrado para ruminantes do qual a gravidade específica é 1,17 a 2,00, o tamanho de partícula máximo e o tamanho de partícula mínimo estão dentro da faixa de 4 a 10 mm, e a resistência à ruptura de uma porção tendo o tamanho de partícula mínimo abaixo do ambiente de temperatura corporal dos ruminantes está dentro da faixa de 0,5 a 5,0 N. A presente invenção também fornece alimentação de ruminante contendo o agente oralmente administrado e um método de administrar um fármaco oralmente a ruminantes.
BR112016017636-7A 2014-01-31 2015-01-30 Agente oralmente administrado a ruminantes e alimentação de ruminante contendo o mesmo BR112016017636B1 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2014-017200 2014-01-31
JP2014017200 2014-01-31
PCT/JP2015/052754 WO2015115618A1 (ja) 2014-01-31 2015-01-30 反芻動物用の経口投与剤およびそれを含む反芻動物用飼料

Publications (2)

Publication Number Publication Date
BR112016017636A2 true BR112016017636A2 (pt) 2017-08-08
BR112016017636B1 BR112016017636B1 (pt) 2021-09-28

Family

ID=53757185

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112016017636-7A BR112016017636B1 (pt) 2014-01-31 2015-01-30 Agente oralmente administrado a ruminantes e alimentação de ruminante contendo o mesmo

Country Status (12)

Country Link
US (1) US20160338948A1 (pt)
EP (1) EP3103351B1 (pt)
JP (1) JP6617562B2 (pt)
CN (1) CN106455633B (pt)
AU (1) AU2015211711B2 (pt)
BR (1) BR112016017636B1 (pt)
CA (1) CA2937666A1 (pt)
DK (1) DK3103351T3 (pt)
MX (1) MX369410B (pt)
PL (1) PL3103351T3 (pt)
RU (1) RU2670930C9 (pt)
WO (1) WO2015115618A1 (pt)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6468633B2 (ja) * 2014-10-03 2019-02-13 富士カプセル株式会社 三層構造シームレスカプセル
JP5989953B1 (ja) * 2015-12-28 2016-09-07 森下仁丹株式会社 粉末状成分含有シームレスカプセルおよびその製造方法
IT201700021852A1 (it) * 2017-02-27 2018-08-27 Bioscreen Tech S R L Composizione a rilascio controllato di sostanze fisiologicamente attive e processo per la sua preparazione
IT201700021879A1 (it) 2017-02-27 2018-08-27 Bioscreen Tech S R L Composizione a rilascio controllato di sostanze fisiologicamente attive e processo per la sua preparazione
CN107467370A (zh) * 2017-10-13 2017-12-15 无锡正大生物股份有限公司 一种饲料用功能性诱食剂及其制备方法
CN109430560A (zh) * 2018-12-25 2019-03-08 内蒙古金河动物药业有限公司 一种氧化锌饲料添加剂及其制备方法和应用
JP7222548B2 (ja) * 2019-12-26 2023-02-15 富士カプセル株式会社 三層構造シームレスカプセル
CN112167165B (zh) 2020-09-29 2022-02-11 厦门汇盛生物有限公司 一种复配过瘤胃多不饱和脂肪酸粉的制备及其应用
AU2021396978A1 (en) 2020-12-08 2023-02-23 Ruminant Biotech Corp Limited Improvements to devices and methods for delivery of substances to animals

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3619200A (en) * 1966-06-21 1971-11-09 Commw Scient Ind Res Org Method and food composition for feeding ruminants
JPS5822062A (ja) 1981-08-03 1983-02-09 森下仁丹株式会社 高融点物質充填微小カプセルの製造方法及び装置
JPS59131355A (ja) 1983-01-17 1984-07-28 森下仁丹株式会社 多重軟カプセルの製法
JPS61195653A (ja) * 1985-02-26 1986-08-29 Mitsui Toatsu Chem Inc 反すう動物用粒子
JP2547995B2 (ja) * 1987-01-26 1996-10-30 昭和電工株式会社 反すう動物用粒剤及びその製造法
US5077052A (en) * 1988-11-30 1991-12-31 Rhone-Poulenc Sante Chitosan derivatives useful in compositions for coating feedstuff additives intended for ruminants
JP2806564B2 (ja) 1989-07-20 1998-09-30 森下仁丹株式会社 親水性物質を内容物とするシームレスカプセルおよびその製法
US5190775A (en) * 1991-05-29 1993-03-02 Balchem Corporation Encapsulated bioactive substances
JP3313124B2 (ja) * 1991-07-31 2002-08-12 森下仁丹株式会社 親水性物質を内容物とするシームレスカプセルおよびその製法
JP3102990B2 (ja) 1993-07-08 2000-10-23 森下仁丹株式会社 カプセルの製造方法およびそれから得られたカプセル
CA2127392C (en) * 1993-07-08 2008-05-27 Hideki Sunohara Process for producing capsule and capsule obtained thereby
CN1124098A (zh) * 1994-10-08 1996-06-12 北京市营养源研究所 过瘤胃制剂的制备方法
GB9500863D0 (en) * 1995-01-17 1995-03-08 Grampian Pharm Ltd Medicated animal foodstuffs
US6238727B1 (en) * 1998-03-04 2001-05-29 Ajinomoto, Co., Inc. Ruminant feed additive composition and process for producing the same
JP2000060440A (ja) * 1998-08-19 2000-02-29 Ajinomoto Co Inc 反芻動物用飼料添加剤組成物の製造法
JP2001120189A (ja) * 1999-10-27 2001-05-08 Meiji Milk Prod Co Ltd 反芻動物用脂肪酸給与組成物
AU2002247950B2 (en) * 2001-04-16 2006-11-09 Jubilant Organosys Limited A rumen bypass composition containing a bioactive substance and a method for its preparation
ITRN20030021A1 (it) * 2003-07-21 2005-01-22 Ascor Chimici Srl Composizione di materia comprendente particelle contenenti cloruro di colina da somministrare in forma ruminalmente protetta e post-ruminalmente efficace.
RU2255800C1 (ru) * 2003-10-14 2005-07-10 Германов Евгений Павлович Магнитоуправляемый сорбент и способ его получения
US20060039955A1 (en) * 2004-05-28 2006-02-23 Cargill, Incorporated Animal feed compositions with enhanced histidine content
ITMI20041820A1 (it) * 2004-09-24 2004-12-24 Ascor Chimici Srl Composizione in micro-pellets a rilascio controllato di sostanze fisiologicamente attive, procedimento di preparazione e relativo impiego nel settore zootecnico.
CN1620904B (zh) * 2004-12-16 2010-05-12 上海高龙生物科技有限公司 反刍动物饲料添加剂
US20070231369A1 (en) * 2006-03-31 2007-10-04 Rlc Technologies, L.L.C. Ruminant feed composition and method of making
KR100698452B1 (ko) * 2006-05-02 2007-03-23 대한민국(관리부서:농촌진흥청) 반추위 보호 콜린의 제조방법
NZ582576A (en) * 2007-06-29 2012-05-25 Takeda Pharmaceutical Seamless capsule comprising gelatin and a plasticizer
CN101467592A (zh) 2007-12-29 2009-07-01 农村振兴厅 保护维生素c的反刍动物饲料添加剂及其制备方法和用途
NZ600720A (en) * 2008-01-10 2012-12-21 Takeda Pharmaceutical A Seamless Capsule For A Liquid Pharmaceutical Composition
CN101543471A (zh) * 2008-03-27 2009-09-30 刘春海 过瘤胃葡萄糖
JP2011125217A (ja) 2008-04-03 2011-06-30 Ajinomoto Co Inc 酸性、中性アミノ酸含有反芻動物用飼料添加組成物及びその製造方法
JP5259253B2 (ja) * 2008-05-19 2013-08-07 森下仁丹株式会社 シームレスカプセル
BRPI1002601E2 (pt) * 2010-06-01 2020-06-30 Embrapa Pesquisa Agropecuaria composição nanoestruturada de uso veterinário para administração de fármacos
JP5957280B2 (ja) * 2012-05-02 2016-07-27 日清ファルマ株式会社 大腸デリバリーシームレスカプセル製剤及びその製造方法

Also Published As

Publication number Publication date
RU2670930C9 (ru) 2018-12-13
PL3103351T3 (pl) 2019-04-30
BR112016017636B1 (pt) 2021-09-28
US20160338948A1 (en) 2016-11-24
AU2015211711B2 (en) 2018-05-10
MX2016009973A (es) 2017-02-28
AU2015211711A1 (en) 2016-08-18
JPWO2015115618A1 (ja) 2017-03-23
EP3103351B1 (en) 2018-11-07
CN106455633A (zh) 2017-02-22
WO2015115618A1 (ja) 2015-08-06
JP6617562B2 (ja) 2019-12-11
EP3103351A1 (en) 2016-12-14
EP3103351A4 (en) 2017-10-25
RU2670930C2 (ru) 2018-10-25
RU2016135040A (ru) 2018-03-05
CA2937666A1 (en) 2015-08-06
CN106455633B (zh) 2020-07-17
DK3103351T3 (en) 2019-01-07
MX369410B (es) 2019-11-07

Similar Documents

Publication Publication Date Title
BR112016017636A2 (pt) Agente oralmente administrado a ruminantes e alimentação de ruminante contendo o mesmo
BR112018014112A8 (pt) Dispositivos e métodos para formação de uma fístula
EA201791702A1 (ru) Терапевтические средства на основе гликанов и связанные с ними способы
BR112016028957A2 (pt) estruturas de residência e métodos relativos
BR112019012071A2 (pt) tratamento de uma doença do trato gastrointestinal com um inibidor de integrina
MX2019006823A (es) Tratamiento de una enfermedad del tracto gastrointestinal con inhibidor de interleucina-12/interleucina-23 (il-12/il-23) liberado usando un dispositivo ingerible.
BR112017004048A2 (pt) formulações de pó inalável de oligômeros de alginato
BR112018007347A2 (pt) dispositivos ajustáveis para o tratamento da artrite do joelho
BR112015022465A2 (pt) método para tratamento não-tóxico para síndrome de abstinência de drogas
BR112016002574A8 (pt) composição de enzima digestiva, processo para a preparação da composição de enzima digestiva, e, método para o tratamento de um paciente adulto ou pediátrico com necessidade da composição de enzima digestiva
MX2016009231A (es) Administracion de tasimelteon en condiciones de ayuno.
BR112012027794A2 (pt) tablete entérico
EP3318251A3 (en) Composition for preventing or treating obesity or lipid-related metabolic disease
BR112015029897A2 (pt) composição sólida para administração oral contendo ácido ibandrônico ou um seu sal farmaceuticamente aceitável e vitamina d e processo para obtenção da referida composição
BR112022003895A2 (pt) Sistema e método de entrega de múltiplos fármacos
BR112017022846A2 (pt) combinação de dose fixa inviolável que proporciona rápida liberação de dois fármacos de partículas diferentes
BR112018014022A2 (pt) dispositivo de ereptiospiração para ceras, sólidos, biopolímeros ou óleos altamente viscosos medicinais e canabinóides
BR112018008778A2 (pt) sistema de formação de imagens por ultrassom, sonda de ultrassom para formação de imagens e método de geração de uma imagem por ultrassom durante um procedimento de bloqueio de nervo
BR112017002878A2 (pt) distribuição coordenada de tratamento de copd
BR112014025973A2 (pt) preparação e método para prevenir e tratar a osteoporose e fraturas ósseas
BR112016029749A2 (pt) composições que compreendem cinamaldeído e zinco e métodos de uso de tais composições
BR112017022335A2 (pt) combinação de dose fixa inviolável que fornece rápida liberação de dois fármacos a partir de partículas e matriz
PH12018500889A1 (en) Pharmaceutical preparation for delivery of porous material to large intestine or lower part of small intestine
BR112017022855A2 (pt) combinação de dose fixa inviolável que provê liberação rápida de dois fármacos a partir de partículas e um pó
PH12016502591B1 (en) Pharmaceutical for treating dizziness having different causes

Legal Events

Date Code Title Description
B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B15K Others concerning applications: alteration of classification

Free format text: AS CLASSIFICACOES ANTERIORES ERAM: A23K 1/18 , A23K 1/16

Ipc: A23K 40/35 (2016.01), A23K 50/10 (2016.01), A61K 3

B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 30/01/2015, OBSERVADAS AS CONDICOES LEGAIS.

B21F Lapse acc. art. 78, item iv - on non-payment of the annual fees in time

Free format text: REFERENTE A 9A ANUIDADE.

B24J Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12)

Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2759 DE 21-11-2023 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.